Author pages are created from data sourced from our academic publisher partnerships and public sources.
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European…
ABCD : Appropriate Blood pressure Control in Diabetes ABI : ankle–brachial index ABPM : ambulatory blood pressure monitoring ACCESS : Acute Candesartan Cilexetil Therapy in Stroke Survival ACCOMPLISH… Expand
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European…
- G. Mancia, R. Fagard, +22 authors F. Zannad
- Political Science, Medicine
- Journal of hypertension
- 1 June 2007
2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of… Expand
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
BACKGROUND Activation of renal sympathetic nerves is key to pathogenesis of essential hypertension. We aimed to assess effectiveness and safety of catheter-based renal denervation for reduction of… Expand
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
- B. Fellström, A. Jardine, +25 authors F. Zannad
- The New England journal of medicine
- 2 April 2009
BACKGROUND Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been… Expand
Renin-angiotensin system and cardiovascular risk
The renin-angiotensin system is a major regulatory system of cardiovascular and renal function. Basic research has revealed exciting new aspects, which could lead to novel or modified therapeutic… Expand
2018 ESC/ESH Guidelines for the management of arterial hypertension.
Introduction The European Society of Cardiology (ESC) and European Society of Hypertension (ESH) jointly issued new guidelines for the management of arterial hypertension, which were presented at the… Expand
Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients
- A. Gradman, R. Schmieder, R. Lins, J. Nussberger, Y. Chiang, M. P. Bedigian
- 1 March 2005
Background—Stopping the detrimental effects of the renin-angiotensin system at the most upstream point of the cascade offers theoretical advantages for cardiovascular protection. This study compares… Expand
Guidelines for management of arterial hypertension
Authors/Task Force Members: Giuseppe Mancia, Co-Chairperson (Italy), Guy De Backer, Co-Chairperson (Belgium), Anna Dominiczak (UK), Renata Cifkova (Czech Republic), Robert Fagard (Belgium), Giuseppe… Expand
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society…
- B. Williams, G. Mancia, +25 authors I. Desormais
- Giornale italiano di cardiologia
- 1 November 2018
Authors/Task Force Members: Bryan Williams* (ESC Chairperson) (UK), Giuseppe Mancia* (ESH Chairperson) (Italy), Wilko Spiering (The Netherlands), Enrico Agabiti Rosei (Italy), Michel Azizi (France),… Expand
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.
- M. Schneider, T. Hua, M. Böhm, K. Wachtell, S. Kjeldsen, R. Schmieder
- Journal of the American College of Cardiology
- 25 May 2010
OBJECTIVES The authors reviewed published clinical trial data on the effects of renin-angiotensin system (RAS) inhibition for the prevention of atrial fibrillation (AF), aiming to define when RAS… Expand